AAPL351.91-0.87 (-0.25%) ▼|ABBV292.82-1.73 (-0.59%) ▼|ABT104.71-2.74 (-2.55%) ▼|ACN239.28-8.42 (-3.40%) ▼|ADBE235.55-10.45 (-4.25%) ▼|AMAT349.23-1.02 (-0.29%) ▼|AMD503.41-0.87 (-0.17%) ▼|AMGN457.93-4.39 (-0.95%) ▼|AMT183.18-7.56 (-3.96%) ▼|AMZN257.89+0.14 (+0.05%) ▲|AVGO341.60+8.20 (+2.46%) ▲|AXP315.78-3.27 (-1.02%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.49-1.23 (-1.13%) ▼|SCHW91.84-1.10 (-1.18%) ▼|SO93.60-1.04 (-1.10%) ▼|SPG230.24-2.54 (-1.09%) ▼|T22.29-0.07 (-0.31%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN295.86+1.65 (+0.56%) ▲|UBER68.81-1.18 (-1.69%) ▼|UNH389.68-22.34 (-5.42%) ▼|UNP297.03-6.68 (-2.20%) ▼|UPS110.31-1.51 (-1.35%) ▼|USB59.18-1.25 (-2.07%) ▼|V416.77-9.69 (-2.27%) ▼|VZ45.93-0.41 (-0.88%) ▼|WFC82.69-2.15 (-2.53%) ▼|WMT127.52-0.89 (-0.69%) ▼|XOM167.21+0.34 (+0.20%) ▲|AAPL351.91-0.87 (-0.25%) ▼|ABBV292.82-1.73 (-0.59%) ▼|ABT104.71-2.74 (-2.55%) ▼|ACN239.28-8.42 (-3.40%) ▼|ADBE235.55-10.45 (-4.25%) ▼|AMAT349.23-1.02 (-0.29%) ▼|AMD503.41-0.87 (-0.17%) ▼|AMGN457.93-4.39 (-0.95%) ▼|AMT183.18-7.56 (-3.96%) ▼|AMZN257.89+0.14 (+0.05%) ▲|AVGO341.60+8.20 (+2.46%) ▲|AXP315.78-3.27 (-1.02%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.49-1.23 (-1.13%) ▼|SCHW91.84-1.10 (-1.18%) ▼|SO93.60-1.04 (-1.10%) ▼|SPG230.24-2.54 (-1.09%) ▼|T22.29-0.07 (-0.31%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN295.86+1.65 (+0.56%) ▲|UBER68.81-1.18 (-1.69%) ▼|UNH389.68-22.34 (-5.42%) ▼|UNP297.03-6.68 (-2.20%) ▼|UPS110.31-1.51 (-1.35%) ▼|USB59.18-1.25 (-2.07%) ▼|V416.77-9.69 (-2.27%) ▼|VZ45.93-0.41 (-0.88%) ▼|WFC82.69-2.15 (-2.53%) ▼|WMT127.52-0.89 (-0.69%) ▼|XOM167.21+0.34 (+0.20%) ▲|
13.7 C
New York
Wednesday, November 18, 2026

Tag: 1

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to...

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC, first-line G/GEJA, and immunotherapy-resistant lung adenocarcinoma, further supporting its...

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

SHANGHAI and HONG KONG, Oct. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to...

26th Shanghai Fair Returns to Kuala Lumpur to Strengthen Trade and Cultural Ties

KUALA LUMPUR, Malaysia, Oct. 26, 2026 /PRNewswire/ -- The 26th Shanghai Fair Trade Show – Malaysia, organized by RCG International Convention & Exhibition Co....

DiDi Shareholders Overwhelmingly Back Hong Kong Relisting; Want Independent Director, Open Earnings Calls, and First Shareholder Meeting in Four Years, Survey Finds

A Heng Ren Partners survey this month finds at least 99.3% support on five key shareholder issues to boost shareholder value; shareholders want DiDi's...

DiDi Shareholders Overwhelmingly Back Hong Kong Relisting; Want Independent Director, Open Earnings Calls, and First Shareholder Meeting in Four Years, Survey Finds

A Heng Ren Partners survey this month finds at least 99.3% support on five key shareholder issues to boost shareholder value; shareholders want DiDi's...

Clarins Lights Up the Austin Skyline with an Immersive Celebration of Skin Longevity

AUSTIN, Texas, Oct. 25, 2026 /PRNewswire/ -- French prestige beauty brand, Clarins, hosted an exclusive rooftop celebration in Austin, Texas, bringing together science, technology...

Tennessee Oncology Researchers Help Lead Global Trial of Next-Generation Lung Cancer Therapy

Research Conducted at Tennessee Oncology's Greco-Hainsworth Centers for Research Contributes to Study Showing Longer Overall Survival with Next-Generation KRAS G12C TherapyNASHVILLE, Tenn., Oct. 25, 2026...

The 31st MIF, 2026PLPEX & 2026MFE Conclude Successfully, Facilitating Cross-Sector Co-operation and Enhancing Investment Promotion through Exhibitions

MACAO, Oct. 25, 2026 /PRNewswire/ -- The 31st Macao International Trade & Investment Fair (31st MIF), the 2026 Portuguese Speaking Countries Products and Services...

Vantrue Announces Early Black Friday Sale with Up to 44% Off Select Dash Cams

November 1–21, 2026 | Official Website: Vantrue.comSHENZHEN, China, Oct. 25, 2026 /PRNewswire/ -- Vantrue, a dash cam brand dedicated to helping drivers capture the...

Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented...

HONG KONG, Oct. 25, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, multicenter, registrational Phase...

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

Responses were deep and durable, with 65% ongoing at clinical cutoffResults support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase...

LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026

A new, modern DORS and Field Clarity, the First AI-Guided Smartphone Video Assistant, Enhances Community Experience and Helps Improve Evidence, Case BuildingORLANDO, Fla., Oct....

From loss to lasting impact: More than $4.5M raised by the Orchid Women’s Health Initiative to change women’s health care in Nova Scotia

HALIFAX, NS, Oct. 25, 2026 /CNW/ -- What began as a tribute to a beloved friend has grown into a multimillion-dollar movement transforming women's...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1